Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
03/06/2024 13:35
June 3 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA THERAPEUTICS INC SAYS ON MAY 31, CO RECEIVED
WRITTEN
NOTICE FROM NASDAQ INDICATING THAT NASDAQ HEARINGS PANEL
DETERMINED TO DELIST CO’S SHARES
* GALERA THERAPEUTICS INC SAYS TRADING IN CO’S SHARES OF
COMMON
STOCK ON NASDAQ WILL BE SUSPENDED EFFECTIVE AT OPEN OF TRADING
ON JUNE 4 - SEC FILING
* GALERA THERAPEUTICS INC - UPON SUSPENSION ON NASDAQ, CO
EXPECTS
COMMON STOCK WILL BE QUOTED UNDER ITS EXISTING SYMBOL “GRTX” ON
OTC
Source text for Eikon: ID:n0001193125-24-152343
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement